Evidence map›Paper›PMID 23873033›Full record

ArticleOptometry and vision science : official publication of the American Academy of Optometry2013

Glaucoma medication adherence among African Americans: program development.

Laura E Dreer, Christopher A Girkin, Lisa Campbell, Andy Wood, Liyan Gao, Cynthia Owsley

Abstract read
In one paragraph

Article in Optometry and vision science : official publication of the American Academy of Optometry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Distribution ofOphthalmology and therapy · 2020
    Article
  12. Increasing Engagement of African American Patients with Glaucoma during Medical Encounters: Creation of a Pre-visit Video.Optometry and vision science : official publication of the American Academy of Optometry · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura E DreerDepartment of Ophthalmology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. dreer@uab.edu
Christopher A Girkin
Lisa Campbell
Andy Wood
Liyan Gao
Cynthia Owsley

Funding

Research Education CoreP30AG031054 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROWTHER, MARTHA R · 2007 to 2025
$11.6M
Problem Solving Training and Low Vision RehabilitationK23EY017327 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DREER, LAURA E · 2006 to 2010
$805k
NEI NIH HHS K23 EY017327NEI NIH HHS K23 EY017327-01NIA NIH HHS P30 AG031054NIA NIH HHS P30AG031054
6 · The paper itself

Abstract

purposeTo elucidate barriers and facilitators related to glaucoma medication adherence among African Americans (AA) with glaucoma and to elicit input from a community-based participatory research team to guide the development of a culturally informed health promotion program for improving glaucoma medication adherence among AAs.

methodsThe nominal group technique (NGT), a highly structured focus group methodology, was implemented with 12 separate groups of AA patients with glaucoma (N = 89) to identify barriers and facilitators related to glaucoma medication usage. Participant rank-ordering votes were summed across groups and categorized into themes. Next, an individually and culturally targeted health promotion program promoting appropriate medication adherence was developed based on focus group results and input from a community-based participatory research team.

resultsThe top five barriers included problems with forgetfulness, side effects, cost/affordability, eyedrop administration, and the eyedrop schedule. The most salient top five facilitators were fear or thoughts about the consequences of not taking eyedrops; use of memory aids, cues, or strategies; maintaining a regular routine or schedule for eyedrop administration; ability to afford eyedrops; and keeping eyedrops in the same area. The resulting health promotion program was based on a multicomponent empowerment framework that included glaucoma education, motivational interviewing, and problem-solving training to improve glaucoma medication adherence.

conclusionsBarriers and facilitators related to glaucoma medication adherence among AAs are multifactorial. Based on the NGT themes and input from the community-based participatory research team, a culturally informed health promotion program was designed and holds great promise for improving medication adherence among this vulnerable population.

Indexed as

Drug MonitoringProgram DevelopmentAdultAgedAged, 80 and overAntihypertensive AgentsBlack or African AmericanFemaleFocus GroupsGlaucomaHealth PromotionHumansMaleMedication AdherenceMiddle AgedAntihypertensive Agents

Identifiers

PMID23873033
PMCPMC3923902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.